Coherent Unveils ACE FL Thulium Fiber Laser

Published: 27 Jun 2025

Author: Precedence Research

Share :

Coherent Corp., a world-leading provider of photonics and laser technology, has unveiled its breakthrough in medical advancement. The ACE FL series is a next-generation thulium fiber laser (TFL) platform specifically designed to meet the needs and requirements of urological therapy. Laser surgery, which is used in the treatment of conditions such as lithotripsy and benign prostatic hyperplasia (BPH), is not only a breakthrough in minimizing surgical errors, time consumption, and risk to the patient.

The ACE FL version is optimized for OEM partners' embedding in laser systems and surgical instruments used in hospital and outpatient settings. It provides better energy management and electrocautery than other devices, which is vital for the sensitive actions carried out during endoscopic urological surgeries. This technology underscores Coherent's commitment to advancing patient care, as well as the ability of medical OEMs to deliver the next generation of devices at a faster and more confident pace.

ACE FL is a special solution to this need. The Coherent thulium fiber laser offers improved thermal and power management, reduced power draw, and enhanced surgical visibility compared to legacy laser technology, enabling faster procedures and shorter recovery times. Such characteristics are especially significant during the enucleation of BPH, as careful removal of tissues is necessary without causing gross blood loss or thermal destruction of adjacent regions.

The strategy, another element that Coherent has adopted to anchor advanced photonics on the ground of clinical application, is also supported by the launch of the ACE FL series. Answering the demands of medical professionals by taking on the challenges that are complicated in integration by OEMs and making the patient outcomes results much more reliable in surgery. Additionally, the Coherent is aiding in closing the gap between engineering mastery and clinical usefulness.

Executive Statements

Martin Seifert, Vice President of Coherent’s High-Power Fiber Laser Business Unit, expressed the company’s vision

“Our new thulium fiber laser is a breakthrough platform that enables medical OEMs to deliver safer, faster, and more effective treatments for kidney stones and BPH. With the growing shift toward outpatient and minimally invasive procedures, the market opportunity for fiber-based surgical lasers is stronger than ever.”